Your browser doesn't support javascript.
loading
Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study.
Matsuba, Ikuro; Kawata, Takehiro; Iemitsu, Kotaro; Asakura, Taro; Amemiya, Hikaru; Ishikawa, Masashi; Ito, Syogo; Kaneshiro, Mizuki; Kanamori, Akira; Kubota, Akira; Shinoda, Kazuaki; Takai, Masahiko; Takuma, Tetsuo; Takihata, Masahiro; Takeda, Hiroshi; Tanaka, Keiji; Matsuzawa, Yoko; Machimura, Hideo; Minagawa, Fuyuki; Minami, Nobuaki; Mokubo, Atsuko; Miyakawa, Masaaki; Terauchi, Yasuo; Tanaka, Yasushi.
Afiliação
  • Matsuba I; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Kawata T; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Iemitsu K; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Asakura T; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Amemiya H; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Ishikawa M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Ito S; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Kaneshiro M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Kanamori A; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Kubota A; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Shinoda K; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Takai M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Takuma T; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Takihata M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Takeda H; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Tanaka K; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Matsuzawa Y; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Machimura H; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Minagawa F; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Minami N; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Mokubo A; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Miyakawa M; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.
  • Terauchi Y; Department of Endocrinology and Metabolism, Yokohama City University, Yokohama, Japan.
  • Tanaka Y; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
J Diabetes Investig ; 11(5): 1248-1257, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32149469
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiofenos / Biomarcadores / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiofenos / Biomarcadores / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article